The molecular and physiological roles of ABCC6: More than meets the eye

Frontiers in Genetics

Volumn 3, Issue DEC, 2012, Pages

  Le Saux, Olivier ^a   Martin, Ludovic ^b   Aherrahrou, Zouhair ^c   Leftheriotis, Georges ^b   Váradi, András ^d   Brampton, Christopher N ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITY OF LÜBECK   (Germany)

^d INSTITUTE OF ENZYMOLOGY   (Hungary)

Author keywords

Thalassemia; ABCC6; Calcification; Ectopic cardiac calcification; Generalized arterial calcification of infancy; Pseudoxanthoma elasticum

Indexed keywords

MUS;

EID: 84876084086     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00289     Document Type: Review

References (93)

1. Aessopos, A., Farmakis, D., Karagiorga, M., Rombos, I., and Loucopoulos, D. (1997). Pseudoxanthoma elas-ticum lesions and cardiac compli cations as contributing factors for strokes in beta-thalassemia patients. Stroke 28, 2421-2424.
2. Aessopos, A., Farmakis, D., and Loukopoulos, D. (2002). Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood 99, 30-35.
3. Aherrahrou, Z. (2003). Histological and Molecular Genetic Analysis of Mice With Genetic Predisposition to Dystrophic Cardiac Calcification in Response to Injury. Ph.D. dissertation, Universität zu Lubeck.
4. Aherrahrou, Z., Axtner, S. B., Kaczmarek, P. M., Jurat, A., Korff, S., Doehring, L. C., et al. (2004). A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. Am. J. Pathol. 164, 1379-1387.
5. Aherrahrou, Z., Doehring, L. C., Ehlers, E. M., Liptau, H., Depping, R., Linsel-Nitschke, P., et al. (2008). An alternative splice variant in Abcc6, the gene causing dystrophic calcifi cation, leads to protein deficiency in C3H/He mice. J. Biol. Chem. 283, 7608-7615.
6. Andrews, N. C. (1998). The NF-E2 transcription factor. Int. J. Biochem. Cell. Biol. 30, 429-432.
7. Aranyi, T., Ratajewski, M., Bardoczy, V., Pulaski, L., Bors, A., Tordai, A., et al. (2005). Identification of a DNA methylation-dependent activator sequence in the pseudox-anthoma elasticum gene, ABCC6. J. Biol. Chem. 280, 18643-18650.
8. Atzeni, F., Sarzi-Puttini, P., and Bevilacqua, M. (2006). Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others). Rheum. Dis. Clin. North Am. 32, 413-426.
9. Baccarani-Contri, M., Bacchelli, B., Boraldi, F., Quaglino, D., Taparelli, F., Carnevali, E., et al. (2001). Characterization of pseudoxan-thoma elasticum-like lesions in the skin of patients with beta-thalassemia. J. Am. Acad. Dermatol. 44, 33-39.
10. Beck, K., Hayashi, K., Dang, K., Hayashi, M., and Boyd, C. D. (2005). Analysis of ABCC6 (MRP6) in normal human tissues. Histochem. Cell Biol. 123, 517-528.
11. Beck, K., Hayashi, K., Nishiguchi, B., Le Saux, O., Hayashi, M., and Boyd, C. D. (2003). The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J. Histochem. Cytochem. 51, 887-902.
12. Belinsky, M. G., Chen, Z. S., Shchaveleva, I., Zeng, H., and Kruh, G. D. (2002). Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 62, 6172-6177.
13. Bergen, A. A., Plomp, A. S., Schuurman, E. J., Terry, S., Breuning, M., Dauwerse, H., et al. (2000). Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 25, 228-231.
14. Berk, D. R., Bentley, D. D., Bayliss, S. J., Lind, A., and Urban, Z. (2012). Cutis laxa: a review. J. Am. Acad. Dermatol. 66, 842 e1-e17.
15. Bloom, S., and Peric-Golia, L. (1989). Geographic variation in the incidence of myocardial calcification associated with acute myocar-dial infarction. Hum. Pathol. 20, 726-731.
16. Boraldi, F., Annovi, G., Vermeer, C., Schurgers, L. J., Trenti, T., Tiozzo, R., et al. (2012). "Matrix Gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts of PXE patients adn controls," in PXE Research Meeting (Bethesda, MD).
17. Boraldi, F., Quaglino, D., Croce, M. A., Garcia Fernandez, M. I., Tiozzo, R., Gheduzzi, D., et al. (2003). Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients. Matrix Biol. 22, 491-500.
18. Borst, P., van de Wetering, K., and Schlingemann, R. (2008). Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 7, 1575-1579.
19. Brampton, C., Aherrahrou, Z., Chen, L. H., Martin, L., Szabó, A., Varadi, A., et al. (2012). "The hepatic expression of ABCC6 determines the severity of mineralization following myocardial necrosis," in FEBS Special Meeting: ABC Proteins (Innsbruck, Austria).
20. Brampton, C., Yamaguchi, Y., Vanakker, O., Van Laer, L., Chen, L. H., Thakore, M., et al. (2011). Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum. Cell Cycle 10, 1810-1820.
21. Brunnert, S. R. (1997). Morphologic response of myocardium to freeze-thaw injury in mouse strains with dystrophic cardiac calcification. Lab. Anim. Sci. 47, 11-18.
22. Chakraborti, T., Das, S., Mondal, M., Roychoudhury, S., and Chakraborti, S. (1999). Oxidant, mitochondria and calcium: an overview. Cell. Signal. 11, 77-85.
23. Chassaing, N., Martin, L., Calvas, P., Le Bert, M., and Hovnanian, A. (2005). Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J. Med. Genet. 42, 881-892.
24. Cianciulli, P., Sorrentino, F., Maffei, L., Amadori, S., Cappabianca, M. P., Foglietta, E., et al. (2002). Cardiovascular involvement in tha-lassaemic patients with pseudoxan-thoma elasticum-like skin lesions: a long-term follow-up study. Eur. J. Clin. Invest. 32, 700-706.
25. Dawson, R. J., and Locher, K. P. (2007). Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett. 581, 935-938.
26. de Boussac, H., Ratajewski, M., Sachrajda, I., Koblos, G., Tordai, A., Pulaski, L., et al. (2010). The ERK1/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes. J. Biol. Chem. 285, 22800-22808.
27. DeGorter, M. K., Conseil, G., Deeley, R. G., Campbell, R. L., and Cole, S. P. (2008). Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochem. Biophys. Res. Commun. 365, 29-34.
28. Doehring, L. C., Kaczmarek, P. M., Ehlers, E., Mayer, B., Erdmann, J., Schunkert, H., et al. (2006). Arterial calcification in mice after freeze-thaw injury. Ann. Anat. 188, 235-242.
29. Douet, V., Heller, M. B., and Le Saux, O. (2007). DNA methyla-tion and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem. Biophys. Res. Commun. 354, 66-71.
30. Douet, V., Van Wart, C. M., Heller, M. B., Reinhard, S., and Le Saux, O. (2006). HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. Biochim. Biophys. Acta 1759, 426-436.
31. Eaton, G. J., Custer, R. P., Johnson, F. N., and Stabenow, K. T. (1978). Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences. Am. J. Pathol. 90, 173-186.
32. Everitt, J. I., Olson, L. M., Mangum, J. B., and Visek, W. J. (1988). High mortality with severe dystrophic cardiac calcinosis in C3H/OUJ mice fed high fat purified diets. Ve t. Pathol. 25, 113-118.
33. Farmakis, D., Moyssakis, I., Perakis, A., Rombos, Y., Deftereos, S., Giakoumis, A., et al. (2003). Unstable angina associated with coronary arterial calcification in a thalassemia intermedia patient with a pseudoxanthoma elasticum-like syndrome. Eur. J. Haematol. 70, 64-66.
34. Farmakis, D., Vesleme, V., Papadogianni, A., Tsaftaridis, P., Kapralos, P., and Aessopos, A. (2004). Aneurysmatic dilatation of ascending aorta in a patient with beta-thalassemia and a pseudox-anthoma elasticum-like syndrome. Ann. Hematol. 83, 596-599.
35. Fulop, K., Barna, L., Symmons, O., Zavodszky, P., and Varadi, A. (2009). Clustering of disease-causing mutations on the domain-domain interfaces of ABCC6. Biochem. Biophys. Res. Commun. 379, 706-709.
36. Fulop, K., Jiang, Q., Wetering, K. V., Pomozi, V., Szabo, P. T., Aranyi, T., et al. (2011). ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: relevance to pathomechanisms of pseudoxan-thoma elasticum. Biochem. Biophys. Res. Commun. 415, 468-471.
37. Garcia-Fernandez, M. I., Gheduzzi, D., Boraldi, F., Paolinelli, C. D., Sanchez, P., Valdivielso, P., et al. (2008). Parameters of oxidative stress are present in the circulation of PXE patients. Biochim. Biophys. Acta 1782, 474-481.
38. Gheduzzi, D., Boraldi, F., Annovi, G., DeVincenzi, C. P., Schurgers, L. J., Vermeer, C., et al. (2007). Matrix Gla protein is involved in elastic fiber calcification in the der-mis of pseudoxanthoma elasticum patients. Lab. Invest. 87, 998-1008.
39. Gheduzzi, D., Sammarco, R., Quaglino, D., Bercovitch, L., Terry, S., Taylor, W., et al. (2003). Extracutaneous ultrastructural alterations in pseu-doxanthoma elasticum. Ultrastruct. Pathol. 27, 375-384.
40. Gorgels, T. G., Waarsing, J. H., Herfs, M., Versteeg, D., Schoensiegel, F., Sato, T., et al. (2011). Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum. J. Mol. Med. (Berl.) 89, 1125-1135.
41. Gotting, C., Hendig, D., Adam, A., Schon, S., Schulz, V., Szliska, C., et al. (2005). Elevated xylosyltrans-ferase I activities in pseudoxan-thoma elasticum (PXE) patients as a marker of stimulated proteogly-can biosynthesis. J. Mol. Med. 83, 984-992.
42. Hamlin, N., Beck, K., Bacchelli, B., Cianciulli, P., Pasquali-Ronchetti, I., and Le Saux, O. (2003). Acquired Pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients. Br. J. Haematol. 122, 852-854.
43. Hendig, D., Adam, A., Zarbock, R., Szliska, C., Kleesiek, K., and Gotting, C. (2008a). Elevated serum levels of intercellular adhesion molecule ICAM-1 in Pseudoxanthoma elasticum. Clin. Chim. Acta 394, 54-58.
44. Hendig, D., Zarbock, R., Szliska, C., Kleesiek, K., and Gotting, C. (2008b). The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin. Biochem. 41, 407-412.
45. Hendig, D., Schulz, V., Arndt, M., Szliska, C., Kleesiek, K., and Gotting, C. (2006). Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudox-anthoma elasticum. Clin. Chem. 52, 227-234.
46. Hirohashi, T., Suzuki, H., and Sugiyama, Y. (1999). Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J. Biol. Chem. 274, 15181-15185.
47. Hornstrup, L. S., Tybjaerg-Hansen, A., Haase, C. L., Nordestgaard, B. G., Sillesen, H., Grande, P., et al. (2011). Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease. Circ. Cardiovasc. Genet. 4, 534-541.
48. Ilias, A., Urban, Z., Seidl, T. L., Le Saux, O., Sinko, E., Boyd, C. D., et al. (2002). Loss of ATP-dependent transport activity in pseudox-anthoma elasticum-associated mutants of human ABCC6 (MRP6). J. Biol. Chem. 277, 16860-16867.
49. Ivandic, B. T., Utz, H. F., Kaczmarek, P. M., Aherrahrou, Z., Axtner, S. B., Klepsch, C., et al. (2001). New Dyscalc loci for myocardial cell necrosis and calcification (dys-trophic cardiac calcinosis) in mice. Physiol. Genomics 6, 137-144.
50. Jiang, Q., Li, Q., Grand-Pierre, A. E., Schurgers, L. J., and Uitto, J. (2011). Administration of vitamin K does not counteract the ectopic mineralization of connective tissues in Abcc6 (-/-) mice, a model for pseu-doxanthoma elasticum. Cell Cycle 10, 701-707.
51. Jiang, Q., Li, Q., and Uitto, J. (2007). Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J. Invest. Dermatol. 127, 1392-1402.
52. Koblos, G., Andrikovics, H., Prohaszka, Z., Tordai, A., Varadi, A., and Aranyi, T. (2010). The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease. Genet. Test. Mol. Biomarkers 14, 75-78.
53. Krumpochova, P., Sapthu, S., Brouwers, J. F., de Haas, M., de Vos, R., Borst, P., et al. (2012). Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays. FASEB J. 26, 738-747.
54. Le Boulanger, G., Labreze, C., Croue, A., Schurgers, L. J., Chassaing, N., Wittkampf, T., et al. (2010). An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am. J. Med. Genet. A 152A, 118-123.
55. Lebwohl, M., Schwartz, E., Lemlich, G., Lovelace, O., Shaikh-Bahai, F., and Fleischmajer, R. (1993). Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum. Arch. Dermatol. Res. 285, 121-126.
56. Le Corre, Y., Brampton, C. N., Bollt, O., Renard, M., Vanakker, O., De Paepe, A., et al. (2012). "The lymphatic vasculature contributes to the calcification phenotype in pseudoxan-thoma elasticum," in PXE Research Meeting (Bethesda, MD).
57. Leftheriotis, G., Abraham, P., Le Corre, Y., Le Saux, O., Henrion, D., Ducluzeau, P. H., et al. (2011a). Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J. Vasc. Surg. 54, 1390-1394.
58. Leftheriotis, G., Vanakker, O., Le Saux, O., and Martin, L. (2011b). Reply to the article of C. Markello et al. entitled "Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum." Mol. Genet. Metab. 103, 199-200.
59. Le Saux, O., Beck, K., Sachsinger, C., Silvestri, C., Treiber, C., Goring, H. H., et al. (2001). A spectrum of abcc6 mutations is responsible for pseudoxanthoma elasticum. Am. J. Hum. Genet. 69, 749-764.
60. Le Saux, O., Bunda, S., Van wart, C. M., Douet, V., Got, L., Martin, L., et al. (2006). Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J. Invest. Dermatol. 126, 1497-1505.
61. Le Saux, O., Fulop, K., Yamaguchi, Y., Ilias, A., Szabo, Z., Brampton, C. N., et al. (2011). Expression and in vivo rescue of human ABCC6 disease-causing mutants in mouse liver. PLoS ONE 6:e24738. doi: 10.1371/journal.pone.0024738
62. Le Saux, O., Urban, Z., Tschuch, C., Csiszar, K., Bacchelli, B., Quaglino, D., et al. (2000). Mutations in a gene encoding an ABC transporter cause pseudox-anthoma elasticum. Nat. Genet. 25, 223-227.
63. Li, Q., Berndt, A., Guo, H., Sundberg, J. P., and Uitto, J. (2012). A novel animal model for pseudoxanthoma elasticum: the KK/HlJ mouse. Am. J. Pathol. 181, 1190-1196.
64. Li, Y. F., Polgar, O., Okada, M., Esser, L., Bates, S. E., and Xia, D. (2007). Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study. J. Mol. Graph. Model. 25, 837-851.
65. Lockard, V. G., and Bloom, S. (1991). Morphologic features and nuclide composition of infarction-associated cardiac myocyte mineralization in humans. Am. J. Pathol. 139, 565-572.
66. Madon, J., Hagenbuch, B., Landmann, L., Meier, P. J., and Stieger, B. (2000). Transport function and hepatocellular localization of mrp6 in rat liver. Mol. Pharmacol. 57, 634-641.
67. Markello, T. C., Pak, L. K., St Hilaire, C., Dorward, H., Ziegler, S. G., Chen, M. Y., et al. (2011). Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseu-doxanthoma elasticum. Mol. Genet. Metab. 103, 44-50.
68. Martin, L., Douet, V., Van Wart, C. M., Heller, M. B., and Le Saux, O. (2011). A mouse model of beta-thalassemia shows a liver-specific down-regulation of Abcc6 expression. Am. J. Pathol. 178, 774-783.
69. Martin, L. J., Lau, E., Singh, H., Vergnes, L., Tarling, E. J., Mehrabian, M., et al. (2012). ABCC6 localizes to the mitochondria-associated membrane. Circ. Res. 111, 516-520.
70. Meng, H., Vera, I., Che, N., Wang, X., Wang, S. S., Ingram-Drake, L., et al. (2007). Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc. Natl. Acad. Sci. U.S.A. 104, 4530-4535.
71. Mungrue, I. N., Zhao, P., Yao, Y., Meng, H., Rau, C., Havel, J. V., et al. (2011). Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model. Arterioscler. Thromb. Vasc. Biol. 31, 2806-2812.
72. Nitschke, Y., Baujat, G., Botschen, U., Wittkampf, T., du Moulin, M., Stella, J., et al. (2012). Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am. J. Hum. Genet. 90, 25-39.
73. Pasquali-Ronchetti, I., Garcia-Fernandez, M. I., Boraldi, F., Quaglino, D., Gheduzzi, D., De Vincenzi Paolinelli, C., et al. (2006). Oxidative stress in fibroblasts from patients with pseudoxan-thoma elasticum: possible role in the pathogenesis of clinical manifestations. J. Pathol. 208, 54-61.
74. Passi, A., Albertini, R., Baccarani Contri, M., de Luca, G., de Paepe, A., Pallavicini, G., et al. (1996). Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Cell Biochem. Funct. 14, 111-120.
75. Pfendner, E. G., Vanakker, O. M., Terry, S. F., Vourthis, S., McAndrew, P. E., McClain, M. R., et al. (2007). Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxan-thoma elasticum. J. Med. Genet. 44, 621-628.
76. Quaglino, D., Boraldi, F., Barbieri, D., Croce, A., Tiozzo, R., and Pasquali Ronchetti, I. (2000). Abnormal phenotype of in vitro dermal fibroblasts from patients with Pseudoxanthoma elasticum (PXE). Biochim. Biophys. Acta 1501, 51-62.
77. Raha, S., and Robinson, B. H. (2001). Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet. 106, 62-70.
78. Ratajewski, M., de Boussac, H., Sachrajda, I., Bacquet, C., Kovacs, T., Varadi, A., et al. (2012). ABCC6 expression is regulated by CCAAT/enhancer-binding protein activating a primate-specific sequence located in the first intron of the gene. J. Invest. Dermatol. 132, 2709-2717.
79. Ravna, A. W., and Sager, G. (2008). Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4). Bioorg. Med. Chem. Lett. 18, 3481-3483.
80. Ravna, A. W., Sylte, I., and Sager, G. (2007). Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5). Theor. Biol. Med. Model. 4, 33.
81. Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., et al. (2008). Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc. Natl. Acad. Sci. U.S.A. 105, 3256-3261.
82. Sinko, E., Ilias, A., Ujhelly, O., Homolya, L., Scheffer, G. L., Bergen, A. A., et al. (2003). Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells. Biochem. Biophys. Res. Commun. 308, 263-269.
83. Smolen, K. K., Gelinas, L., Franzen, L., Dobson, S., Dawar, M., Ogilvie, G., et al. (2012). Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination. Va c c i n e 30, 3572-3579.
84. Szabo, Z., Varadi, A., Li, Q., and Uitto, J. (2011). ABCC6 does not transport adenosine - relevance to pathome-chanism of pseudoxanthoma elas-ticum. Mol. Genet. Metab. 104, 421. author reply: 2.
85. Thein, S. L. (1998). Beta-thalassaemia. Baillieres Clin. Haematol. 11, 91-126.
86. Trip, M. D., Smulders, Y. M., Wegman, J. J., Hu, X., Boer, J. M., ten Brink, J. B., et al. (2002). Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation 106, 773-775.
87. Uitto, J., Pulkkinen, L., and Ringpfeil, F. (2001). Molecular genetics of pseu-doxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Mol. Med. 7, 13-17.
88. Van, Q. N., Issaq, H. J., Jiang, Q., Li, Q., Muschik, G. M., Waybright, T. J., et al. (2008). Comparison of 1D and 2D NMR spectroscopy for metabolic profiling. J. Proteome Res. 7, 630-639.
89. Vanakker, O. M., Martin, L., Gheduzzi, D., Leroy, B. P., Loeys, B. L., Guerci, V. I., et al. (2007). Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J. Invest. Dermatol. 127, 581-587.
90. Vanakker, O. M., Martin, L., Schurgers, L. J., Quaglino, D., Costrop, L., Vermeer, C., et al. (2010). Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. Lab. Invest. 90, 895-905.
91. van den Berg, J. S., Hennekam, R. C., Cruysberg, J. R., Steijlen, P. M., Swart, J., Tijmes, N., et al. (2000). Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxan-thoma elasticum. Cerebrovasc. Dis. 10, 315-319.
92. Vos, M., Esposito, G., Edirisinghe, J. N., Vilain, S., Haddad, D. M., Slabbaert, J. R., et al. (2012). Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science 336, 1306-1310.
93. Zolnerciks, J. K., Wooding, C., and Linton, K. J. (2007). Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB J. 21, 3937-3948.